Comparative Analysis of Diclofenac, Naproxen, and Etoricoxib using AI

Authors

  • Md Naim Mukabbir Author

Keywords:

Osteoarthritis, NSAIDs, Pain Management, Artificial Intelligence, Adverse Events

Abstract

In this paper, Osteoarthritis is a debilitating joint 
disease affecting millions worldwide, characterized by 
pain, stiffness, and reduced mobility.  Effective pain 
management is crucial for improving patients' quality 
of life. Nonsteroidal anti-inflammatory drugs are 
commonly prescribed for OA pain relief, but they 
exhibit varying efficacy and safety profiles. This study 
employs AI-driven analysis to compare three 
frequently used NSAIDs: diclofenac, naproxen, and 
etoricoxib.  
Utilizing and we analyzed data from 
patients diagnosed with OA.  We evaluated the 
efficacy of each NSAID by assessing pain reduction 
using and gauged safety by monitoring the incidence 
of 
adverse 
events, 
including 
gastrointestinal 
complications, cardiovascular events, and renal effects.  
Our analysis revealed .  These findings provide 
valuable insights for clinicians in personalizing OA 
treatment plans, optimizing pain management while 
minimizing potential risks associated with each 
NSAID. 

Downloads

Published

2024-10-20

How to Cite

Comparative Analysis of Diclofenac, Naproxen, and Etoricoxib using AI. (2024). Bulletin of Engineering Science and Technology , 1(1), 42-56. https://boengstech.com/index.php/bestec/article/view/6

Similar Articles

11-17 of 17

You may also start an advanced similarity search for this article.